Japanese Biotech Stock News

TSE:4536
TSE:4536Pharmaceuticals

MHRA Approval of Ryjunea® Could Be a Game Changer for Santen Pharmaceutical (TSE:4536)

In the past week, Santen Pharmaceutical announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) approved Ryjunea® (low-dose atropine 0.1 mg/ml) as the first licensed treatment to slow the progression of myopia in children, following earlier European Commission approval and launches in Europe. This milestone offers Santen a new opportunity to address the rising prevalence of childhood myopia in the UK and further strengthens its international presence in paediatric...
TSE:3563
TSE:3563Hospitality

Will Food & Life (TSE:3563) Earnings Insights Shape Investor Confidence in Its Long-Term Strategy?

Food & Life Companies recently held its 2025 earnings call on November 7, 2025, providing investors with updates on its financial and operational performance. This regular event serves as a key opportunity for stakeholders to assess the company's progress and reassess expectations going forward. With the earnings call drawing attention, we'll explore how updated financial insights may influence Food & Life Companies’ investment narrative. We've found 16 US stocks that are forecast to pay a...